Best TWAS P=3.7e-11 · Best GWAS P=2.32e-11 conditioned to 0.0283
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Aorta | TMOD3 | 0.17 | 0.02 | enet | 11 | 0.05 | 7.1e-04 | -5.7 | -5.8 | 8.7e-09 | -0.34 | 0.25 | 0.71 | FALSE |
2 | GTEx | Artery Aorta | GLDN | 0.19 | 0.03 | lasso | 9 | 0.08 | 3.0e-05 | 5.9 | -5.8 | 7.3e-09 | -0.53 | 0.41 | 0.57 | FALSE |
3 | GTEx | Artery Tibial | GLDN | 0.10 | 0.02 | lasso | 6 | 0.05 | 1.2e-04 | 3.8 | -5.6 | 2.0e-08 | -0.32 | 0.43 | 0.18 | TRUE |
4 | GTEx | Artery Tibial | RP11-707P17.2 | 0.07 | 0.01 | lasso | 5 | 0.01 | 3.3e-02 | 6.4 | 6.5 | 1.1e-10 | 0.84 | 0.05 | 0.76 | FALSE |
5 | GTEx | Cells EBV-transformed lymphocytes | DMXL2 | 0.17 | 0.13 | lasso | 3 | 0.06 | 4.2e-03 | 6.7 | 6.2 | 6.9e-10 | 0.97 | 0.04 | 0.92 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | DMXL2 | 0.06 | 0.06 | lasso | 3 | 0.05 | 5.9e-05 | 6.3 | -6.3 | 2.8e-10 | -0.54 | 0.27 | 0.65 | FALSE |
7 | GTEx | Cells Transformed fibroblasts | TMOD2 | 0.09 | 0.10 | enet | 8 | 0.10 | 3.0e-08 | -6.4 | -6.4 | 1.3e-10 | -0.44 | 0.10 | 0.90 | FALSE |
8 | GTEx | Esophagus Mucosa | DMXL2 | 0.09 | 0.01 | lasso | 2 | 0.00 | 1.7e-01 | 5.3 | -5.9 | 3.1e-09 | -0.68 | 0.18 | 0.38 | FALSE |
9 | GTEx | Esophagus Muscularis | TMOD2 | 0.07 | 0.03 | lasso | 3 | 0.00 | 2.8e-01 | 5.1 | -5.4 | 7.7e-08 | -0.68 | 0.06 | 0.71 | FALSE |
10 | GTEx | Muscle Skeletal | LYSMD2 | 0.23 | 0.23 | lasso | 4 | 0.21 | 1.6e-20 | -6.5 | 6.6 | 3.7e-11 | 0.47 | 0.06 | 0.94 | TRUE |
11 | GTEx | Skin Not Sun Exposed Suprapubic | TMOD3 | 0.05 | 0.07 | enet | 13 | 0.07 | 6.4e-05 | -6.4 | 6.3 | 3.8e-10 | 0.44 | 0.14 | 0.83 | FALSE |
12 | GTEx | Skin Sun Exposed Lower leg | TMOD3 | 0.07 | 0.07 | enet | 22 | 0.06 | 6.0e-06 | -6.4 | 6.5 | 9.8e-11 | 0.46 | 0.09 | 0.91 | FALSE |
13 | GTEx | Thyroid | MAPK6 | 0.04 | 0.02 | lasso | 4 | 0.01 | 8.8e-02 | -5.6 | 6.4 | 2.0e-10 | 0.43 | 0.25 | 0.50 | FALSE |
14 | GTEx | Thyroid | LEO1 | 0.05 | 0.05 | lasso | 3 | 0.04 | 3.7e-04 | -5.5 | 5.6 | 1.9e-08 | 0.37 | 0.50 | 0.40 | FALSE |
15 | METSIM | Adipose | TMOD2 | 0.03 | 0.03 | lasso | 10 | 0.02 | 1.9e-03 | -5.6 | -5.5 | 3.1e-08 | -0.42 | 0.77 | 0.21 | FALSE |
16 | NTR | Blood | TMOD2 | 0.07 | 0.09 | enet | 29 | 0.09 | 3.0e-28 | -5.5 | -5.7 | 1.5e-08 | -0.42 | 0.94 | 0.06 | FALSE |
17 | YFS | Blood | TMOD2 | 0.10 | 0.19 | bslmm | 435 | 0.19 | 4.4e-60 | -5.5 | -5.5 | 4.6e-08 | -0.46 | 0.97 | 0.03 | FALSE |
18 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TMOD2 | 0.04 | 0.03 | blup | 76 | 0.04 | 5.5e-05 | -5.7 | -5.7 | 1.1e-08 | -0.41 | 0.09 | 0.91 | FALSE |
19 | The Cancer Genome Atlas | Lung Adenocarcinoma | SCG3 | 0.06 | 0.02 | blup | 67 | 0.03 | 5.3e-04 | 6.2 | -6.2 | 6.6e-10 | -0.79 | 0.07 | 0.83 | FALSE |
20 | The Cancer Genome Atlas | Lung Adenocarcinoma | TMOD2 | 0.02 | 0.01 | blup | 78 | 0.02 | 2.3e-03 | -5.7 | -6.5 | 7.4e-11 | -0.43 | 0.04 | 0.83 | FALSE |
21 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | TMOD2 | 0.13 | 0.10 | lasso | 2 | 0.07 | 1.0e-03 | 5.8 | -5.9 | 4.4e-09 | -0.23 | 0.04 | 0.66 | FALSE |
22 | The Cancer Genome Atlas | Stomach Adenocarcinoma | LYSMD2 | 0.06 | 0.01 | blup | 74 | 0.01 | 5.2e-02 | -5.5 | 5.2 | 1.7e-07 | 0.19 | 0.02 | 0.26 | FALSE |
23 | The Cancer Genome Atlas | Thyroid Carcinoma | LEO1 | 0.14 | 0.12 | enet | 7 | 0.13 | 9.2e-13 | -6.4 | 5.8 | 7.9e-09 | 0.40 | 0.00 | 1.00 | FALSE |
24 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | LYSMD2 | 0.17 | 0.06 | enet | 4 | 0.05 | 2.1e-02 | 5.3 | -5.8 | 7.7e-09 | -0.44 | 0.03 | 0.34 | FALSE |